Dehradun’s Rajat Jain is no ordinary entrepreneur. Backed by the Startup India initiative, he built a thriving company that’s democratizing heart disease screening, turning high-end diagnostics into everyday essentials.
The spark ignited during the pandemic when Jain witnessed families crippled by exorbitant medical bills. Focusing on electrocardiograms (ECGs) and biomarker analysis, his team engineered a compact diagnostic kit that rivals imported machines but costs 80% less.
Startup India’s ecosystem played a pivotal role—from DPIIT recognition to access to angel investors. Within two years, the startup scaled production, employing 50 locals and exporting prototypes to Southeast Asia.
What sets this apart? The device’s machine-learning algorithms analyze data in real-time, flagging risks like arrhythmias or blockages with 95% precision. Users simply attach sensors to their chest, sync with an app, and get a report in minutes.
Health experts hail it as a game-changer. ‘This bridges the urban-rural divide in cardiac care,’ notes Dr. Meera Singh, a leading cardiologist. Adoption is surging: from Uttarakhand villages to Delhi slums, it’s becoming a household name.
Jain’s story is inspirational. ‘Innovation thrives when supported by policy,’ he reflects. With plans for nationwide expansion, his venture exemplifies how startups can tackle India’s biggest health challenges head-on.
